Veru Inc.

Veru Inc.

Biotechnology Research Miami, Fl, United States 53 employees
Employees
53
Contacts
3
Emails
3
Phones
2

Veru Inc. Overview

Headquarters
Miami, Fl, United States
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
53
Founded
2014
Funding
33.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Veru Inc.

Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed as a next generation drug that makes weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass thereby improving body composition and physical function. Sabizabulin, a microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease.

Veru Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Veru Inc. Org Chart

Sample employees and titles
Name Title Contact
Philip Greenberg Executive Vice President - Deputy
Email Phone
Grace Hyun, Md Associate Professor at Nyu Langone
View
Kevin Gilbert Executive Vice President Corporate
Email Phone
Dawn Fitzpatrick Human Resources, IT & Office Manager
Email

Employees by Management Level

Individual contributor 5 profiles
Executive 3 profiles
Director 3 profiles
Associate / junior 3 profiles
Manager 2 profiles

Department Contact Coverage

Department Contacts Email Phone
Executive 3 3 1
Healthcare 1 1 0

Compare Similar Companies to Veru Inc.